Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis

Blood

Volumn 110, Issue 12, 2007, Pages 4096-4100

  Piperno, Alberto ^a   Girelli, Domenico ^b   Nemeth, Elizabeta ^c   Trombini, Paola ^a   Bozzini, Claudia ^b   Poggiali, Erika ^d   Phung, Yen ^c   Ganz, Tomas ^c   Camaschella, Clara ^d  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEPCIDIN; IRON;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HEMOCHROMATOSIS; HEMOCHROMATOSIS GENE; HETEROZYGOTE; HOMOZYGOTE; HORMONE SYNTHESIS; HORMONE URINE LEVEL; HUMAN; IRON DEPLETION; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; PHLEBOTOMY; PRIORITY JOURNAL; REGULATOR GENE; URINARY EXCRETION;

EID: 37049024131     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-06-096503     Document Type: Article

References (23)

1. Camaschella C. Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders. Blood. 2005;106:3710-3717.
2. Pietrangelo A. Hereditary hemochromatosis - a new look at an old disease. N Engl J Med. 2004; 350:2383-2397.
3. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G-> -A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet. 2002;359:211-218.
4. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med. 1999;341:718-724.
5. Asberg A, Hveem K, Thorstensen K, et al. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65 238 persons. Scand J Gastroenterol. 2001;36:1108-1115.
6. Olynyk JK, Hagan SE, Cullen DJ, Beilby J, Whittall DE. Evolution of untreated hereditary hemochromatosis in the Busselton population: a 17-year study. Mayo Clin Proc. 2004;79:309-313.
7. Andersen RV, Tybjaerg-Hansen A, Appleyard M, Birgens H, Nordestgaard BG. Hemochromatosis mutations in the general population: iron overload progression rate. Blood. 2004;103:2914-2919.
8. Ganz T. Hepcidin-a regulator of intestinal iron absorption and iron recycling by macrophages. Best Pract Res Clin Haematol. 2005;18:171-182.
9. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090-2093.
10. Bridle KR, Frazer DM, Wilkins SJ, et al. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet. 2003;361:669-673.
11. Gehrke SG, Kulaksiz H, Herrmann T, et al. Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to the serum transferrin saturation and to non-transferrin-bound iron. Blood. 2003;102:371-376.
12. Gleeson F, Ryan E, Barrett S, Russell J, Crowe J. Hepatic iron metabolism gene expression profiles in HFE associated hereditary hemochromatosis. Blood Cells Mol Dis. 2007;38:37-44.
13. Ahmad KA, Ahmann JR, Migas MC, et al. Decreased liver hepcidin expression in the HFE knockout mouse. Blood Cells Mol Dis. 2002;29:361-366.
14. Muckenthaler M, Roy CN, Custodio AO, et al. Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis. Nat Genet. 2003;34:102-107.
15. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113:1271-1276.
16. Vokurka M, Krijt J, Sulc K, Necas E. Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis. Physiol Res. 2006;55:667-674.
17. Pak M, Lopez MA, Gabayan V, Ganz T, Rivera S. Suppression of hepcidin during anemia requires erythropoietic activity. Blood. 2006;108:3730-3735.
18. Nicolas G, Chauvet C, Viatte L, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002;110:1037-1044.
19. Piperno A, Arosio C, Fargion S, et al. The ancestral hemochromatosis haplotype is associated with a severe phenotype expression in Italian patients. Hepatology. 1996;24:43-46.
20. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acutephase protein. Blood. 2003;101:2461-2463.
21. Papanikolaou G, Tzilianos M, Christakis JI, et al. Hepcidin in iron overload disorders. Blood. 2005;105:4103-4105.
22. Lin L, Valore EV, Nemeth E, Goodnough JB, Gabayan V, Ganz T. Iron-transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4. Blood. 2007;110:2182-2189.
23. EASL International Consensus Conference on Haemochromatosis, III: jury document. J Hepatol. 2000;33:496-504.